Copyright Open Access This article is licensed under a Creative Commons Attribution 4.0 International License ( which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
A study investigated whether weight loss was sustained better one year after termination of a GLP-1, supervised exercise program, or combined for one year
Key Points: Metformin is first-line for type 2 diabetes
Rochael Vogt Local Guide Level 3
Promote lean muscle definition and body composition goals
Weight loss response to naltrexone/bupropion is modulated by the taq1A genetic variant near DRD2 (rs1800497): A pilot study